Your browser doesn't support javascript.
loading
Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B.
Takahashi, Yukitoshi; Nishimura, Shigeko; Takao, Emiko; Kasai, Risa; Enokida, Kaoru; Ida, Kuniko; Fukuoka, Masataka; Koike, Takayoshi; Omatsu, Hiroo; Yamaguchi, Tokito; Takano, Shiho; Yoshida, Tomoyuki; Mori, Hisashi.
Affiliation
  • Takahashi Y; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan; Department of Pediatrics, Gifu University School of Medicine, Yanagido, Gifu, Japan; School of Pharmaceutical Sciences, University of Shizuoka, Japan. Electronic addre
  • Nishimura S; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: 307-seika@mail.hosp.go.jp.
  • Takao E; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: takao.emiko.ev@mail.hosp.go.jp.
  • Kasai R; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: 307-yakuri@mail.hosp.go.jp.
  • Enokida K; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: 307-seiri@mail.hosp.go.jp.
  • Ida K; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: ida.kuniko.qb@mail.hosp.go.jp.
  • Fukuoka M; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: taka0730@shizuokamind.org.
  • Koike T; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: koike.takayoshi.bk@mail.hosp.go.jp.
  • Omatsu H; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: hrw-ohmatsu@umin.ac.jp.
  • Yamaguchi T; National Epilepsy Center, NHO, Shizuoka Institute of Epilepsy and Neurological Disorders, 886 Urushiyama, Aoi-ward, Shizuoka, Japan. Electronic address: tokito@shizuokamind.org.
  • Takano S; Department of Molecular Neuroscience, Graduate Schools of Innovative Life Science and Medicine, University of Toyama, Toyama, Japan.
  • Yoshida T; Department of Molecular Neuroscience, Graduate Schools of Innovative Life Science and Medicine, University of Toyama, Toyama, Japan. Electronic address: toyoshid@med.u-toyama.ac.jp.
  • Mori H; Department of Molecular Neuroscience, Graduate Schools of Innovative Life Science and Medicine, University of Toyama, Toyama, Japan. Electronic address: hmori@med.u-toyama.ac.jp.
J Neuroimmunol ; 349: 577427, 2020 12 15.
Article in En | MEDLINE | ID: mdl-33091764
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Autoantibodies / Receptors, N-Methyl-D-Aspartate / Nerve Tissue Proteins Limits: Animals / Humans Language: En Journal: J Neuroimmunol Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Autoantibodies / Receptors, N-Methyl-D-Aspartate / Nerve Tissue Proteins Limits: Animals / Humans Language: En Journal: J Neuroimmunol Year: 2020 Type: Article